HealthCare Global Enterprises Limited

NSEI:HCG 주식 보고서

시가총액: ₹51.8b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

HealthCare Global Enterprises 미래 성장

Future 기준 확인 4/6

HealthCare Global Enterprises (는) 각각 연간 46.8% 및 11.8% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 46.8% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 11.4% 로 예상됩니다.

주요 정보

46.8%

수익 성장률

46.8%

EPS 성장률

Healthcare 수익 성장25.7%
매출 성장률11.8%
향후 자기자본 수익률11.4%
애널리스트 커버리지

Good

마지막 업데이트31 May 2024

최근 미래 성장 업데이트

HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next

Feb 11
HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next

Recent updates

HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next

Feb 11
HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next

We Think Shareholders Will Probably Be Generous With HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation

Sep 14
We Think Shareholders Will Probably Be Generous With HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation

A Look At The Fair Value Of HealthCare Global Enterprises Limited (NSE:HCG)

Sep 05
A Look At The Fair Value Of HealthCare Global Enterprises Limited (NSE:HCG)

HealthCare Global Enterprises Limited's (NSE:HCG) Business Is Yet to Catch Up With Its Share Price

May 17
HealthCare Global Enterprises Limited's (NSE:HCG) Business Is Yet to Catch Up With Its Share Price

Does HealthCare Global Enterprises (NSE:HCG) Have A Healthy Balance Sheet?

Jun 24
Does HealthCare Global Enterprises (NSE:HCG) Have A Healthy Balance Sheet?

Shareholders Shouldn’t Be Too Comfortable With HealthCare Global Enterprises' (NSE:HCG) Strong Earnings

Jun 03
Shareholders Shouldn’t Be Too Comfortable With HealthCare Global Enterprises' (NSE:HCG) Strong Earnings

Is HealthCare Global Enterprises (NSE:HCG) Using Too Much Debt?

Dec 08
Is HealthCare Global Enterprises (NSE:HCG) Using Too Much Debt?

What Does HealthCare Global Enterprises Limited's (NSE:HCG) Share Price Indicate?

Jun 25
What Does HealthCare Global Enterprises Limited's (NSE:HCG) Share Price Indicate?

Insider Buying: The HealthCare Global Enterprises Limited (NSE:HCG) Executive Chairman Just Bought ₹2.4m Worth Of Shares

Mar 14
Insider Buying: The HealthCare Global Enterprises Limited (NSE:HCG) Executive Chairman Just Bought ₹2.4m Worth Of Shares

The HealthCare Global Enterprises (NSE:HCG) Share Price Is Up 51% And Shareholders Are Holding On

Mar 03
The HealthCare Global Enterprises (NSE:HCG) Share Price Is Up 51% And Shareholders Are Holding On

Here's Why HealthCare Global Enterprises (NSE:HCG) Can Afford Some Debt

Jan 27
Here's Why HealthCare Global Enterprises (NSE:HCG) Can Afford Some Debt

How Many HealthCare Global Enterprises Limited (NSE:HCG) Shares Did Insiders Buy, In The Last Year?

Dec 23
How Many HealthCare Global Enterprises Limited (NSE:HCG) Shares Did Insiders Buy, In The Last Year?

Reflecting on HealthCare Global Enterprises' (NSE:HCG) Share Price Returns Over The Last Three Years

Nov 10
Reflecting on HealthCare Global Enterprises' (NSE:HCG) Share Price Returns Over The Last Three Years

What Type Of Shareholders Own The Most Number of HealthCare Global Enterprises Limited (NSE:HCG) Shares?

Sep 18
What Type Of Shareholders Own The Most Number of HealthCare Global Enterprises Limited (NSE:HCG) Shares?

수익 및 매출 성장 예측

NSEI:HCG - 애널리스트의 미래 추정치 및 과거 재무 데이터 (INR Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
3/31/202728,4212,618N/AN/A1
3/31/202624,2701,3882,254N/A9
3/31/202521,7888422,015N/A8
3/31/202419,193398915N/A9
12/31/202318,592353N/AN/AN/A
9/30/202318,1403719222,197N/A
6/30/202317,471309N/AN/AN/A
3/31/202316,9442931,1842,516N/A
12/31/202216,174270N/AN/AN/A
9/30/202215,507-2641,1562,364N/A
6/30/202214,827694N/AN/AN/A
3/31/202213,9785371,4892,201N/A
12/31/202113,312-544N/AN/AN/A
9/30/202112,472-3791,0891,510N/A
6/30/202111,431-1,633N/AN/AN/A
3/31/202110,134-1,9358511,205N/A
12/31/20209,858-1,349N/AN/AN/A
9/30/20209,897-1,2847511,271N/A
6/30/202010,202-1,284N/AN/AN/A
3/31/202010,956-1,0672231,301N/A
12/31/201910,832-718N/AN/AN/A
9/30/201910,541-552N/AN/AN/A
6/30/201910,210-394N/AN/AN/A
3/31/20199,787-248-903985N/A
12/31/20189,430-135N/AN/AN/A
9/30/20189,004-41N/AN/AN/A
6/30/20188,661124N/AN/AN/A
3/31/20188,307205-1,583978N/A
12/31/20177,909257N/AN/AN/A
9/30/20177,608278N/AN/AN/A
6/30/20177,237219N/AN/AN/A
3/31/20177,001230N/A913N/A
12/31/20166,705208N/AN/AN/A
9/30/20166,392133N/AN/AN/A
6/30/20166,08167N/AN/AN/A
3/31/20165,842-178N/A732N/A
12/31/20155,611-33N/AN/AN/A
9/30/20155,4949N/A763N/A
6/30/20155,3239N/AN/AN/A
3/31/20155,1948N/A597N/A
3/31/20144,513-356N/A514N/A

애널리스트 미래 성장 예측

수입 대 저축률: HCG 의 연간 예상 수익 증가율( 46.8% )이 saving rate( 6.7% 보다 높습니다. ).

수익 vs 시장: HCG 의 연간 수익( 46.8% ) Indian 시장( 15.9% 보다 빠르게 성장할 것으로 예상됩니다. 15.9% 연간).

고성장 수익: HCG 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: HCG 의 수익(연간 11.8% ) Indian 시장( 9.5% 보다 빠르게 성장할 것으로 예상됩니다. 9.5% 연간).

고성장 수익: HCG 의 수익(연간 11.8% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: HCG 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 11.4 %).


성장 기업 발견